LETERMOVIR ETHYL ESTER

UNII:	E5N4S9C9PL
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₁H₃₂F₄N₄O₄
Preferred Substance Name:	LETERMOVIR ETHYL ESTER
InChIKey:	XGILHIFGLQYHON-VWLOTQADSA-N
GSRS Full Record:	E5N4S9C9PL i

2758792-79-7
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, ethyl ester, (4S)-
Ethyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate
Ethyl (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetate
Letermovir ethyl ester

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LETERMOVIR ETHYL ESTER

Synonyms and Mappings

Resources